KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Other Accumulated Expenses (2016 - 2026)

Supernus Pharmaceuticals has reported Other Accumulated Expenses over the past 13 years, most recently at $38.2 million for Q4 2025.

  • Quarterly Other Accumulated Expenses changed N/A to $38.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $38.2 million for FY2025, N/A changed from the prior year.
  • Other Accumulated Expenses was $38.2 million for Q4 2025 at Supernus Pharmaceuticals, up from $26.3 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $38.2 million in Q4 2025 and troughed at $710000.0 in Q3 2023.
  • The 5-year median for Other Accumulated Expenses is $8.2 million (2022), against an average of $12.2 million.
  • Year-over-year, Other Accumulated Expenses tumbled 91.33% in 2023 and then skyrocketed 664.7% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $20.1 million in 2021, then fell by 16.24% to $16.9 million in 2022, then crashed by 74.6% to $4.3 million in 2023, then fell by 15.41% to $3.6 million in 2024, then surged by 954.98% to $38.2 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Other Accumulated Expenses are $38.2 million (Q4 2025), $26.3 million (Q3 2025), and $27.7 million (Q2 2025).